Secondary prevention in patients with coronary artery disease in Russia and Europe: results from the Russian part of the EUROASPIRE V survey-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Secondary prevention in patients with coronary artery disease in Russia and Europe: results from the Russian part of the EUROASPIRE V survey

Published:2020-12-31 Issue:6 Volume:19 Page:2739
ISSN:2619-0125
Container-title:Cardiovascular Therapy and Prevention
language:
Short-container-title:Cardiovasc Ther Prev

Author:

Pogosova N. V.¹^ORCID,Oganov R. G.²^ORCID,Boytsov S. A.¹^ORCID,Ausheva A. K.¹^ORCID,Sokolova O. Yu.¹^ORCID,Kursakov A. A.²^ORCID,Osipova I. V.³^ORCID,Antropova O. N.³^ORCID,Pozdnyakov Yu. M.⁴^ORCID,Salbieva A. O.²^ORCID,Lelchuk I. N.²^ORCID,Gusarova T. A.²^ORCID,Gomyranova N. V.¹^ORCID,Skazin N. A.⁵^ORCID,Kotseva K.⁶^ORCID

Affiliation:

1. National Medical Research Center of Cardiology

2. National Research Center for Therapy and Preventive Medicine

3. Regional Clinical Hospital

4. Zhukovsky City Clinical Hospital

5. F. I. Inozemtsev City Clinical Hospital № 36

6. National Institute for Prevention and Cardiovascular Health; National University of Ireland – Galway; Imperial College Healthcare NHS Trust

Publisher

Silicea - Poligraf, LLC

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. Timmis A, Townsend N, Gale CP, et al. European Society of Cardiology: Cardiovascular Disease Statistics 2019. Eur Heart J. 2020;41(1):12-85. doi:10.1093/eurheartj/ehz859.

2. Piepoli MF, Abreu A, Albus C, et al. Update on cardiovascular prevention in clinical practice: A position paper of the European Association of Preventive Cardiology of the European Society of Cardiology. Eur J Prev Cardiol. 2020;27(2):181-205. doi:10.1177/2047487319893035.

3. Pogosova NV, Oganov RG, Suvorov SV. Why cardiovascular mortality in Moscow is lower than regions of the Russian Federation? Cardiovascular Therapy and Prevention 2015;14(2):4-12. (In Russ.) Погосова Н.В., Оганов Р.Г., Суворов С.В. Почему в Москве смертность от сердечно-сосудистых заболеваний ниже, чем в других регионах Российской Федерации? Кардиоваскулярная терапия и профилактика. 2015;14(2):4-12. doi:10.15829/1728-8800-2015-2-4-12.

4. EUROASPIRE Study Group. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results. Eur Heart J. 1997;18:1569-82. doi:10.1093/oxfordjournals.eurheartj.a015136.

5. EUROASPIRE II Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries: principal results from EUROASPIRE II. Eur Heart J. 2001;22:554-72. doi:10.1053/euhj.2001.2610.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term consequences and secondary prevention in patients who suffered acute coronary syndrome in real clinical practice based on the results of a 12-year follow-up;CardioSomatics;2024-08-17

2. Electronic medical information and analytical system (EMIAS) as a tool for the new level of understanding and diagnosis of medication adherence in patients with myocardial infarction in primary care practice in Moscow;Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice;2024-07-02

3. Preventive Cardiology 2024: State of Problem Perspectives of Development;Kardiologiia;2024-01-31

4. Possibilities to raise public awareness on primary prevention of cardiovascular diseases;The Siberian Journal of Clinical and Experimental Medicine;2023-01-18

5. Experience of treating patients with mixed hypertriglyceridemia in a lipid center (clinical case);Complex Issues of Cardiovascular Diseases;2023-01-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3